Skip to main content

Plus Therapeutics Inc (PSTV) Stock

Plus Therapeutics Inc Stock Details, Movements and Public Alerts

Stock Details

Plus Therapeutics Inc (PSTV), a prominent company in the healthcare sector within the biotechnology industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $0.63. Over the past 52 weeks, it has ranged between $0.16 and $2.31. This places the current price at 27.3% of its 52-week high and 293.8% above its 52-week low. Recent trading volume was recorded at 2,485,384. The 14-day Relative Strength Index (RSI) stands at 61.01, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $0.61 by 3.28%. Similarly, it is above its 200-day moving average of $0.59 by 6.78%. The MACD histogram is 0.01, indicating bullish momentum (MACD Line: 0.03, Signal Line: 0.02). There are currently 2 active alerts set for PSTV by users.

52-Week Range

$2.31 - $0.16

-72.73% from high · +293.75% from low

Avg Daily Volume

6,227,764

20-day average

100-day avg: 16,790,600

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Price to Book

18.59

EV/EBITDA

-0.30

EPS (TTM)

-$0.96

Price to Sales

17.87

Beta

0.82

Less volatile than market

How is PSTV valued relative to its earnings and growth?
Valuation data is not available for this stock.
What is PSTV's risk profile compared to the market?
With a beta of 0.82, Plus Therapeutics Inc is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 18.59 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

0.00%

Operating Margin

-320.80%

EBITDA

$-12,957,000

Return on Equity

-522.00%

Return on Assets

-65.60%

Revenue Growth (YoY)

-4.10%

Earnings Growth (YoY)

0.00%

How profitable and efficient is PSTV's business model?
0 The operating margin of -320.80% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -522.00% and ROA at -65.60%, the company achieves moderate returns on invested capital.
What are PSTV's recent growth trends?
Plus Therapeutics Inc's revenue declined by 4.10% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions.0 These growth metrics should be evaluated against BIOTECHNOLOGY industry averages for proper context.

Company Size & Market

Market Cap

$94.0M

Revenue (TTM)

$5.26M

Revenue/Share (TTM)

$0.12

Shares Outstanding

137.43M

Book Value/Share

$0.04

Asset Type

Common Stock

What is PSTV's market capitalization and position?
Plus Therapeutics Inc has a market capitalization of $94.0M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 137.43M shares outstanding, the company's ownership is relatively concentrated. As a participant in the BIOTECHNOLOGY industry, it competes with other firms in this sector.
How does PSTV's price compare to its book value?
Plus Therapeutics Inc's book value per share is $0.04, while the current stock price is $0.63, resulting in a price-to-book (P/B) ratio of 16.58. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$7.16

1036.51% upside potential

Analyst Recommendations

Strong Buy

1

Buy

3

Hold

0

Sell

0

Strong Sell

0

How reliable are analyst predictions for PSTV?
4 analysts cover PSTV with 100% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $7.16 implies 1036.5% upside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on PSTV?
Current analyst recommendations:1 Strong Buy, 3 Buy, 000The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Dec 14, 2025, 02:00 AM

Technical Indicators

RSI (14-day)

61.01

Neutral

50-Day Moving Average

$0.61

3.28% above MA-50

200-Day Moving Average

$0.59

6.78% above MA-200

MACD Line

0.03

MACD Signal

0.02

MACD Histogram

0.01

Bullish

What does PSTV's RSI value tell investors?
The RSI (Relative Strength Index) for PSTV is currently 61.01, indicating the stock is showing bullish momentum (60-70 range). The stock has positive momentum without being extremely overbought. This zone often occurs during healthy uptrends where buyers remain in control. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
How should traders interpret PSTV's MACD and moving average crossovers?
MACD analysis shows the MACD line at 0.03 above the signal line at 0.02, with histogram at 0.01. This bullish crossover suggests upward momentum is building. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($0.61) is above the 200-day MA ($0.59), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Dec 15, 2025, 12:31 AM

Active Alerts

Alert Condition
Price decreases by
Threshold
7%
Created
Dec 11, 2025, 04:48 PM
Alert Condition
Volume change
Threshold
200%
Created
Dec 3, 2025, 04:48 PM

Stay Ahead of the Market with Plus Therapeutics Inc Alerts

Set up price alerts for Plus Therapeutics Inc and get notified instantly when the price hits your target. Never miss an important price movement again.